Literature DB >> 6361266

Specific attachment of nuclear-mitotic apparatus protein to metaphase chromosomes and mitotic spindle poles: possible function in nuclear reassembly.

J Van Ness, D E Pettijohn.   

Abstract

NuMA protein is the largest, abundant, primate-specific chromosomal protein. The protein was purified from HeLa cells and monospecific monoclonal antibodies were prepared that react exclusively with NuMA protein in immunoblot analysis. These antibodies were used to define the intracellular location and properties of NuMA protein. Using indirect immunofluorescence, NuMA protein was detected only in the nucleus of interphase cells and on the chromosomes in mitotic cells. One class of monoclonal antibody called the 2E4-type antibody, caused NuMA protein (or a complex of proteins including NuMA) to be released from its binding site on metaphase or anaphase chromosomes. The separation of NuMA protein from chromosomes was observed either with the immunofluorescence assay or in electrophoretic analyses of proteins released from isolated metaphase chromosomes after reaction with 2E4 antibody. The immunofluorescence studies also showed that after release of the NuMA protein from chromosomes of metaphase or anaphase cells, the protein bound specifically to the polar region of the mitotic spindle. It was shown that exogenously added NuMA antigen/antibody complex bound only to the mitotic spindle poles of permeabilized primate cells and not to the spindle poles of other mammalian cells, thus demonstrating the specificity of the spindle-pole interaction. The antibody mediated transfer of NuMA from chromosomes to poles was blocked when the chromosomes were treated with cross-linking fixatives. Results suggest that the NuMA protein has specific attachment sites on both metaphase chromosomes and mitotic spindle poles (the site where post-mitotic nuclear assembly occurs). A model is proposed suggesting that a protein having such dual binding sites could function during nuclear reassembly to link mitotic chromosomes into the reforming nucleus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361266     DOI: 10.1016/s0022-2836(83)80352-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Chromosomal passengers: toward an integrated view of mitosis.

Authors:  W C Earnshaw; R L Bernat
Journal:  Chromosoma       Date:  1991-03       Impact factor: 4.316

2.  Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor.

Authors:  K Ye; D A Compton; M M Lai; L D Walensky; S H Snyder
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins.

Authors:  J Van Ness; U K Laemmli; D E Pettijohn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

4.  A cis-element in the Notch1 locus is involved in the regulation of gene expression in interneuron progenitors.

Authors:  Evangeline Tzatzalos; Shannon M Smith; Sung Tae Doh; Hailing Hao; Ying Li; Alson Wu; Martin Grumet; Li Cai
Journal:  Dev Biol       Date:  2012-09-27       Impact factor: 3.582

5.  Primary structure of NuMA, an intranuclear protein that defines a novel pathway for segregation of proteins at mitosis.

Authors:  D A Compton; I Szilak; D W Cleveland
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

6.  Cell cycle-regulated membrane binding of NuMA contributes to efficient anaphase chromosome separation.

Authors:  Zhen Zheng; Qingwen Wan; Gerry Meixiong; Quansheng Du
Journal:  Mol Biol Cell       Date:  2013-12-26       Impact factor: 4.138

7.  The mitotic protein NuMA plays a spindle-independent role in nuclear formation and mechanics.

Authors:  Andrea Serra-Marques; Ronja Houtekamer; Dorine Hintzen; John T Canty; Ahmet Yildiz; Sophie Dumont
Journal:  J Cell Biol       Date:  2020-12-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.